DE68928415T2 - Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung - Google Patents

Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung

Info

Publication number
DE68928415T2
DE68928415T2 DE68928415T DE68928415T DE68928415T2 DE 68928415 T2 DE68928415 T2 DE 68928415T2 DE 68928415 T DE68928415 T DE 68928415T DE 68928415 T DE68928415 T DE 68928415T DE 68928415 T2 DE68928415 T2 DE 68928415T2
Authority
DE
Germany
Prior art keywords
patient
lollipop
compositions
desired effect
lipophile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68928415T
Other languages
English (en)
Other versions
DE68928415D1 (de
Inventor
Theodore Stanley
Brian Hague
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Utah Research Institute UURI
Original Assignee
University of Utah Research Institute UURI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Utah Research Institute UURI filed Critical University of Utah Research Institute UURI
Application granted granted Critical
Publication of DE68928415D1 publication Critical patent/DE68928415D1/de
Publication of DE68928415T2 publication Critical patent/DE68928415T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
DE68928415T 1989-09-05 1989-09-05 Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung Expired - Lifetime DE68928415T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/003801 WO1991003233A1 (en) 1989-09-05 1989-09-05 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs

Publications (2)

Publication Number Publication Date
DE68928415D1 DE68928415D1 (de) 1997-12-04
DE68928415T2 true DE68928415T2 (de) 1998-02-26

Family

ID=22215208

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68928415T Expired - Lifetime DE68928415T2 (de) 1989-09-05 1989-09-05 Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung

Country Status (8)

Country Link
EP (1) EP0493380B1 (de)
JP (1) JP2758985B2 (de)
AT (1) ATE159658T1 (de)
AU (2) AU645966B2 (de)
DE (1) DE68928415T2 (de)
DK (1) DK175773B1 (de)
NO (2) NO920854L (de)
WO (1) WO1991003233A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH624011A5 (de) * 1977-08-05 1981-07-15 Battelle Memorial Institute
DK0745380T3 (da) * 1995-05-11 2005-12-05 Univ Utah Res Found Tobakserstatning
US20060051413A1 (en) * 2004-09-08 2006-03-09 Chow Sing S M Method of enhancing absorptions of transmucosal administration formulations
WO2007090113A2 (en) * 2006-02-01 2007-08-09 Weg Stuart L Use of antifungal compositions to treat upper gastrointestinal conditions
US20160022643A1 (en) * 2014-07-22 2016-01-28 Professional Compounding Centers Of America Oral Transmucosal Compositions including Aromatase Inhibitors for Low Testosterone Levels in Men
EP3200764B1 (de) 2014-10-01 2020-07-22 Oxytone Bioscience B.V. Im mund zerfallende feste pharmazeutische dosiereinheit mit partuskontrollsubstanz
JP6607509B2 (ja) 2014-10-01 2019-11-20 オキシトーン バイオサイエンス ビー．ブイ． 分娩制御物質を含有する口腔内崩壊性固形医薬投与単位
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
WO2020212948A1 (en) 2019-04-17 2020-10-22 Compass Pathfinder Limited Methods of treating neurocognitive disorders, chronic pain and reducing inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2208120A (en) * 1938-03-02 1940-07-16 William B Coleman Pharmaceutical preparation and method of making same
US3943928A (en) * 1974-09-25 1976-03-16 Lariccia Anthony H Eliminating the safety hazard in oral dissolution of a solid
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
US4551329A (en) * 1984-01-20 1985-11-05 Joan Harris Oral medicament lollipop
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics

Also Published As

Publication number Publication date
AU6069794A (en) 1994-06-23
AU645966B2 (en) 1994-02-03
NO920854D0 (no) 1992-03-04
NO920855L (no) 1992-04-10
DK175773B1 (da) 2005-02-14
DE68928415D1 (de) 1997-12-04
EP0493380A4 (en) 1992-10-07
DK30092A (da) 1992-05-05
DK30092D0 (da) 1992-03-05
EP0493380B1 (de) 1997-10-29
EP0493380A1 (de) 1992-07-08
NO920855D0 (no) 1992-03-04
WO1991003233A1 (en) 1991-03-21
AU5035290A (en) 1991-04-08
ATE159658T1 (de) 1997-11-15
JP2758985B2 (ja) 1998-05-28
JPH05501854A (ja) 1993-04-08
NO920854L (no) 1992-04-27

Similar Documents

Publication Publication Date Title
Bowles et al. Evaluation of new gingival retraction agents
DE69822665T2 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
Kennedy et al. Intravenous regional analgesia: an appraisal
DE69230112D1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
NL990012I2 (nl) Geneesmiddelen die salmeterol en fluticason bevatten.
Kesteloot et al. Clinical experience with lorcainide (R 15 889), a new anti-arrhythmic drug
ATE92762T1 (de) Medikamente.
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
DE68928415T2 (de) Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung
DE59508961D1 (de) Verwendung von weihrauch zur behandlung der alzheimer-krankheit
ATE89737T1 (de) Behandlung von leukozytstoerungen mit gm-csf.
DE58903659D1 (de) Pharmazeutische zubereitung zur behandlung entzuendeter nasenschleimhaeute.
Yaacob et al. The efficacy of xylocaine topical anaesthetic in reducing injection pain
Patel et al. A clinical appraisal of Anacyclus pyrethrum root extract in dental patients
Sugai et al. Sequential changes in the fade of tetanic tension after the administration of tubocurarine in anaesthetized man
Shore, SC,* Weinberg, EG* & Durr Buccal administration of fenoterol aerosol in young children with asthma
DE69431430T2 (de) Faktor XIII zur Behandlung von Hautwunden
DE4236069A1 (de) Arzneimittel, insbesondere für orale Einnahme
EP0397211A3 (de) Perkutane Verabreichung von 3'-Azido-3'-Deoxythymidin
Reynolds et al. Circulatory versus respiratory deaths from pentothal sodium
JPS6442423A (en) Remedy containing propaphenone antipode
RU94018748A (ru) Лекарственный сбор для лечения больных с нарушениями сердечного ритма
Suresh et al. Surgery in Siddha System
CN2233753Y (zh) 护心袋

Legal Events

Date Code Title Description
8364 No opposition during term of opposition